Evidence map›Paper›PMID 21718590›Full record

ReviewChinese journal of cancer2011

Mouse models of medulloblastoma.

Xiaochong Wu, Paul A Northcott, Sidney Croul, Michael D Taylor

Abstract readReview
In one paragraph

Review in Chinese journal of cancer, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Fly · 2022
    Article
  8. Article
  9. Frontiers in oncology · 2021
    Review
  10. Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Molecular Classification of Medulloblastoma.Neurologia medico-chirurgica · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiaochong WuArthur and Sonia Labatt Brain Tumor Research Center, Hospital for Sick Children, Toronto, Ontario, M5G 1L7, Canada.
Paul A Northcott
Sidney Croul
Michael D Taylor

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medulloblastoma is the most common malignant pediatric brain tumor. Despite its prevalence and importance in pediatric neuro-oncology, the genes and pathways responsible for its initiation, maintenance, and progression remain poorly understood. Genetically engineered mouse models are an essential tool for uncovering the molecular and cellular basis of human diseases, including cancer, and serve a valuable role as preclinical models for testing targeted therapies. In this review, we summarize how such models have been successfully applied to the study of medulloblastoma over the past decade and what we might expect in the coming years.

Indexed as

Cerebellar NeoplasmsDisease Models, AnimalGenetic EngineeringMedulloblastomaAnimalsHedgehog ProteinsHumansMiceMice, TransgenicMutationPatched ReceptorsReceptors, Cell SurfaceReceptors, G-Protein-CoupledRNA InterferenceRNA, Small InterferingSignal TransductionHedgehog ProteinsPatched ReceptorsReceptors, Cell SurfaceReceptors, G-Protein-CoupledRNA, Small InterferingSmoothened ReceptorSMO protein, humanTumor Suppressor Protein p53

Identifiers

PMID21718590
PMCPMC4013419

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.